Tokyo, Feb. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060583) titled 'Gastroesophageal Reflux and AF Recurrence After Ablation' on Feb. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Shimane university
Condition:
Condition - Atrial Fibrillation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to exploratorily evaluate the association between atrial fibrillation ablation and gastroesophageal reflux disease.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients scheduled to undergo catheter ablation for atrial fibrillation (AF).
Patients aged 18 years or older at the time of informed consent.
Patients who have provided written informed consent to participate in the study.
Key exclusion criteria - 1) Patients with any of the following diseases:
Esophageal cancer
Pharyngeal cancer
Gastric cancer
Esophageal varices
2) Patients with any of the following conditions:
Esophageal stricture
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 22 Day
Date of IRB - 2025 Year 12 Month 22 Day
Anticipated trial start date - 2026 Year 03 Month 03 Day
Last follow-up date - 2032 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069267
Disclaimer: Curated by HT Syndication.
